Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer.
Andrew T LenisVignesh RavichandranSamantha BrownSyed M AlamAndrew KatimsHong TruongPeter A ReiszSamantha VasselmanBarbara NwejiKaren A AutioMichael J MorrisSusan F SlovinDana E RathkopfDaniel Costin DanilaSungmin WooHebert Alberto VargasVincent P LaudoneBehfar EhdaieVictor ReuterMaria E ArcilaMichael F BergerAgnes VialeHoward I ScherNikolaus SchultzAnuradha GopalanMark T A DonoghueIrina OstrovnayaKonrad H StopsackDavid B SolitWassim AbidaPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
MSI-H/dMMR prostate cancers have greater TMB, indel, and neoantigen burden than TMB-H/MSS prostate cancers, and these differences may contribute to profound and durable responses to ICB.